User banner image
User avatar
  • admin

Posts

TradFi vs. Crypto: Bybit Launches 300,000 USDT Trading Challenge as Copy Trading Gains Momentum in Volatility

DUBAI, UAE, Feb. 10, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is calling traders across the TradFi and crypto divide to come...

dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH)

Press Release dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH) Kaiseraugst (Switzerland), Maastricht (Netherlands), February 9, 2026 Following...

Net Asset Value

9 February 2026 NORTHERN 2 VCT PLC UNAUDITED NET ASSET VALUE AS AT 31 DECEMBER 2025 Northern 2 VCT PLC (“the Company”) is a Venture...

Net Asset Value

9 February 2026 NORTHERN VENTURE TRUST PLC UNAUDITED NET ASSET VALUE AS AT 31 DECEMBER 2025 Northern Venture Trust PLC (“the Company”) is a Venture...

Net Asset Value

9 FEBRUARY 2026 NORTHERN 3 VCT PLC UNAUDITED NET ASSET VALUE AS AT 31 DECEMBER 2025 Northern 3 VCT PLC (“the Company”) is a Venture...

dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners

Press Release dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners Kaiseraugst (Switzerland), Maastricht (Netherlands), February 9, 2026 dsm-firmenich, innovators in...

Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer

MALVERN, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness...

Media Advisory: Wear Red Canada highlights heart disease crisis facing Canadian women

OTTAWA, Ontario, Feb. 09, 2026 (GLOBE NEWSWIRE) — Canadians will mark Wear Red Canada Day on February 13, a national awareness initiative focused on women’s...

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

–   First quarter fiscal 2026 revenue increased 0.8% compared to prior year quarter to $120.9 million   –   First quarter fiscal 2026 operating loss increased...

NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company’s Growth and Execution of Its Mission in Spinal Cord Injury

VANCOUVER, British Columbia, Feb. 09, 2026 (GLOBE NEWSWIRE) — NervGen Pharma Corp. (“NervGen” or the “Company”) (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing...